valsartan has been researched along with fps-zm1 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahmad, SNS; Argani, H; Aslani, S; Ghorbani Haghjo, A; Jigheh, ZA; Mesgari Abbasi, M; Panah, F; Rashedi, J; Roshangar, L; Sanajou, D | 1 |
| Ahmad, SNS; Argani, H; Ashrafi-Jigheh, Z; Asiaee, F; Aslani, S; Bahrambeigi, S; Ghorbani Haghjo, A; Rashedi, J; Rashtchizadeh, N; Roshangar, L; Sanajou, D | 1 |
2 other study(ies) available for valsartan and fps-zm1
| Article | Year |
|---|---|
FPS-ZM1 and valsartan combination protects better against glomerular filtration barrier damage in streptozotocin-induced diabetic rats.
Topics: Administration, Oral; Angiotensin II Type 1 Receptor Blockers; Animals; Benzamides; Biomarkers; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Drug Therapy, Combination; Glomerular Filtration Barrier; Injections, Intraperitoneal; Macrophages; Male; Microscopy, Fluorescence; Phosphorylation; Podocytes; Protein Processing, Post-Translational; Random Allocation; Rats, Wistar; Receptor for Advanced Glycation End Products; Renal Insufficiency; Transcription Factor RelA; Valsartan | 2018 |
Reduction of renal tubular injury with a RAGE inhibitor FPS-ZM1, valsartan and their combination in streptozotocin-induced diabetes in the rat.
Topics: Animals; Benzamides; Collagen; Diabetes Mellitus, Experimental; Drug Interactions; Epithelial Cells; Fibrosis; Glycation End Products, Advanced; Kidney Tubules; Male; Oxidative Stress; Rats; Rats, Wistar; Valsartan | 2019 |